Endocrinology
VinBrain and FIT Utilizing AI in Tuberculosis Screening in Veitnam
Tuberculosis is the leading cause of deaths worldwide from an infectious disease, second only to COVID-19. Vietnam ranks 11th among t...
June 10, 2021 | News
FDA’s Decision to Approve New Treatment for Alzheimer’s Disease
This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...
June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research
“700,000 people in USA are living with primary brain tumour”
Brain tumors originate from the brain itself, or it can be secondary extension from other parts. Brain tumors in India comes to 5-10 in 100,000 popul...
June 08, 2021 | Opinion
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress
Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...
June 08, 2021 | Analysis
Arctic Vision Announces the Treatment of Dry Eye Disease
iTEAR®100 is an FDA-cleared external neurostimulation device that increases acute tear production. Arctic Vision, a clinical stage biotech company foc...
June 07, 2021 | News
Molecules in Saliva May Hold the Key to Tracking Improvements in Autism
According to a recently published study, specific RNA molecules in saliva were found to be strongly associated with autistic behaviors in older individuals...
June 04, 2021 | News
Cognoa Receives FDA Marketing Authorization for Autism Diagnosis Aid
– Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health...
June 03, 2021 | News
TLC and Strides partner to launch Black Fungus Drug in India
TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...
June 02, 2021 | News
Eisai and ITO EN aim to contribute to the solution of dementia
Eisai Co., Ltd. and ITO EN, LTD. announced today that both parties have entered into a business alliance agreement concerning the initiatives for supportin...
June 01, 2021 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
